Comparison of C-reactive protein with distinct hyperinflammatory biomarkers in association with COVID-19 severity, mortality and SARS-CoV-2 variants.

MLA

Paranga, Tudorita Gabriela, et al. “Comparison of C-Reactive Protein with Distinct Hyperinflammatory Biomarkers in Association with COVID-19 Severity, Mortality and SARS-CoV-2 Variants.” Frontiers in Immunology, vol. 14, June 2023, p. 1213246. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1213246.

APA

Paranga, T. G., Pavel-Tanasa, M., Constantinescu, D., Plesca, C. E., Petrovici, C., Miftode, I.-L., Moscalu, M., Cianga, P., & Miftode, E. G. (2023). Comparison of C-reactive protein with distinct hyperinflammatory biomarkers in association with COVID-19 severity, mortality and SARS-CoV-2 variants. Frontiers in Immunology, 14, 1213246. https://doi.org/10.3389/fimmu.2023.1213246

Chicago

Paranga, Tudorita Gabriela, Mariana Pavel-Tanasa, Daniela Constantinescu, Claudia Elena Plesca, Cristina Petrovici, Ionela-Larisa Miftode, Mihaela Moscalu, Petru Cianga, and Egidia Gabriela Miftode. 2023. “Comparison of C-Reactive Protein with Distinct Hyperinflammatory Biomarkers in Association with COVID-19 Severity, Mortality and SARS-CoV-2 Variants.” Frontiers in Immunology 14 (June): 1213246. doi:10.3389/fimmu.2023.1213246.